Maxicity Holdings Limited (HKG:2295)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,708	1,160	620	544	580	216
Market Cap Growth	87.10%	87.10%	13.97%	-6.21%	168.52%	30.12%
Enterprise Value	2,646	1,110	500	422	483	158
Last Close Price	6.77	2.90	1.47	1.20	1.27	0.47
PE Ratio	309.66	132.65	44.47	37.58	20.86	5.49
PS Ratio	13.16	5.64	3.69	2.83	1.97	0.78
PB Ratio	33.10	14.18	4.33	3.22	3.75	1.70
P/TBV Ratio	33.10	14.18	4.33	3.22	3.75	1.70
P/FCF Ratio	152.99	65.53	165.69	19.39	16.18	12.87
P/OCF Ratio	120.78	51.74	148.97	15.93	15.80	11.16
EV/Sales Ratio	12.86	5.39	2.97	2.19	1.64	0.57
EV/EBITDA Ratio	202.73	90.28	34.32	29.38	10.40	3.58
EV/EBIT Ratio	-	127.09	42.78	35.08	10.77	3.68
EV/FCF Ratio	149.49	62.71	133.53	15.02	13.48	9.41
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.00	0.00
Debt / EBITDA Ratio	0.11	0.11	0.05	0.11	0.00	0.01
Debt / FCF Ratio	0.08	0.08	0.21	0.06	0.01	0.03
Asset Turnover	1.48	1.48	0.90	0.98	1.69	2.05
Quick Ratio	3.42	3.42	6.74	5.30	5.62	4.52
Current Ratio	3.61	3.61	6.96	5.51	5.74	4.63
Return on Equity (ROE)	7.78%	7.78%	8.93%	8.94%	19.75%	36.71%
Return on Assets (ROA)	3.91%	3.91%	3.90%	3.81%	16.11%	19.92%
Return on Capital (ROIC)	4.81%	4.81%	4.64%	4.61%	19.89%	24.94%
Return on Capital Employed (ROCE)	10.50%	10.50%	8.10%	7.00%	28.90%	33.70%
Earnings Yield	0.32%	0.75%	2.25%	2.66%	4.79%	18.22%
FCF Yield	0.65%	1.53%	0.60%	5.16%	6.18%	7.77%
Dividend Yield	-	-	1.70%	6.28%	-	-
Payout Ratio	800.46%	800.46%	286.90%	-	-	-
Buyback Yield / Dilution	-	-	-	-	-	-30.94%
Total Shareholder Return	-	-	1.70%	6.28%	-	-30.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.